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 Case    Control    P 
  mean  range  mean  range   
Area (cm2)           
Superior sagittal sinus  17.16  12.39‐22.82  18.20  12.35‐24.19  0.170 
Right sinus transversus  5.39  3.72‐8.55  5.74  2.17‐8.47  0.052 
Left sinus transversus  4.23  1.76‐6.39  4.73  2.63‐7.95  0.124 
Rectus  2.54  1.44‐3.86  2.75  1.55‐4.32  0.126 
           
Superior sagittal sinus 
diameter (cm) 
         
Anterior  0.42  0.30‐0.57  0.44  0.23‐0.68  0.238 
Middle  0.90  0.56‐1.49  0.97  0.64‐1.39  0.108 











  Acute    Follow‐up    P 
           
Sinus Area (Cm2)  mean  range  mean  range   
Superior sagittal sinus  19.67  14.2‐2.1  17.16  12.4‐22.8  <0.001 
Transverse sinus, right  6.07  3.4‐9.4  5.35  3.7‐8.6  0.009 
Transverse sinus, left  4.84  2.2‐8.0  4.23  1.8‐6.4  0.002 
Straight sinus  3.21  2.0‐5.9  2.54  1.4‐3.9  0.005 
           
Trombus Area (Cm2)           
Superior sagittal sinus, n=15  4.12  0.3‐11.1  0.79  0.0‐6.4  0.006 
Transverse sinus, right , n=17  2.43  0.0‐6.1  0.42  0.0‐1.7  0.001 
Transverse sinus, left, n=10  2.49  0.6‐4.3  0.33  0.0‐1.1  0.005 
Straight sinus, n=5  1.64  0.5‐3.1  0  0.0‐0.0  0.043 
           
Thrombus volume (Cm3)           
Total, n=25  4.59  0.6‐15.7  0.54  0.0‐3.0  <0.001 
Superior sagittal sinus, n=15  2.23  0.1‐7.0  0.35  0.0‐2.5  0.002 
Transverse sinus, right, n=17  3.32  0.2‐14.7  0.31  0.0‐1.2  <0.001 
Transverse sinus, left, n=10  1.81  0.5‐2.7  0.27  0.0‐1.1  0.004 
Straight sinus, n=5  0.56  0.1‐1.3  0  0.0‐0.0  0.043 










   Mean  P  Mean  P 
            
Gender     0.009     0.475 
    Male  1.93     0.76    
    Female  5.84     0.43    
              
Age     1.00     0.007 
    <44 years  4.77     0.24    
    ≥44 years  4.31     0.98    
              
Mode of onset     0.543     0.690 
    Acute  8.84     0.34    
    Subacute  6.15     0.73    
    Chronic  2.78     0.66    
              
MRI Imaging     0.156     0.780 
    No parenchymal lesions  5.24     0.56    
    Parenchymal lesion(s)  2.43     0.45    
              
Clinical presentation     0.584     0.975 
    Isolated headache  5.87     0.4    
    Focal symptoms  3.04     0.62    
    Impaired conscioussness  1.46     0.36    
              
Risk Factors     0.723     0.128 
    ≥1 identified risk factor(s) (n=14)  5.43     0.69    
    No identified risk factor (n=1)  5.45     0.45    
             
Outcome     0.254     0.359 
    Good recovery (mRS 0‐1) (n=16)  4.69     0.62    
Incomplete recovery (mRS<2) (n=3)  1.84     0.12 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Discussion 
Cerebral venous thrombosis is a rare disease with various manifestations and is usually 
difficult to diagnose. With improved early diagnosis and quickly started treatments, the 
prognosis of the disease has clearly improved and mortality rates are already below 10%. 
However, considering that most patients are rather young and many survive with 
significant morbidities, there is still room for enhancing both diagnostics and treatment 
modalities. 
There exists no previous work attempting at measuring clot size in CVT patients. 
Therefore, there are no data describing whether large thrombi remain without 
recanalization, lead to more severe consequences, and long‐term disabilities.  If large 
thrombi are associated with dismal outcomes, then, novel approaches e.g. local 
thrombolysis or surgical removal of thrombus from superficial sinuses may be warranted. 
These high‐risk interventions often require an early estimate of likelihood of spontaneous 
recanalization and measurement of clot size.  
One previous study investigated the cerebral venous volume in patients with idiopathic 
intracranial hypertension (27). In that study volume measurements were taken from 
reconstructed 3D images from MRV images without contrast. Therefore the methodology 
differed from ours. In our method manually approximating the thrombus matter in sinuses 
does not suffer from bias caused by slow blood flow and noncontinuous thrombus matter. 
Another unexplored issue is whether the size of the cerebral sinuses differs significantly 
among adult individuals and whether size of the sinuses might be a factor predisposing to 
thrombosis. Because the sinus size cannot be measured reliably upon presence of 
thrombus in it, we considered only patients with recanalization at 6 or 12 months post‐
thrombosis presuming that sinus size returned to its original size at this point of time. For 
this part of the study, we recruited age‐ and sex‐matched patients who underwent brain 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MRI for various headaches and imaging excluded CVT as well as other serious brain 
pathology.  
The trend of CVT patients having smaller sinus size in control imaging compared to healthy 
control subjects could be an undiscovered risk factor for CVT combined with other 
prothrombotic factors. However, it did not reach a statistical significance and could reflect 
reactive shrinkage in exposing these individuals to different venous blood flow conditions, 
or merely a chance finding.  Significance of this is finding should be studied more 
extensively. 
Thrombosed sinuses were clearly engorged in the acute phase followed by significant 
reduction in sinus size after total or partial recanalization. Theoretically this could be 
explained by recanalization of the occluded sinus resulting in lessening the flow 
obstruction and venous congestion.  
The more effective dissolving of the thrombus in women may be related to the fact that 
gender‐specific risk factors play a bigger role in women with CVT, namely contraceptive 
pill, HRT, pregnancy, and puerperium. These are often transient and easily treated 
compared to other risk factors.  Similarly the finding of greater residual volume of the 
thrombus in older age group may reflect the smaller role of these transient risk factors in 
these patients. 
In previous studies the correlation between outcome and recanalization has been unclear. 
Some studies have found no correlation (28) and some have reported higher frequency of 
residual symptoms or worse outcome with no recanalization (29,30). In this study there 
was no correlation between outcome and residual thrombus volume or volume change. 
The lack of correlation between thrombus size and risk factors or clinical factors in this 
study may be due to a small sample size and should be investigated in a larger population. 
Our work has certain limitations. Firstly, the number of patients is rather small. Secondly, 
sinus size at 6 or 12 months post‐CVT may still be different from its original size. Thirdly, 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there is no well‐established gold standard methodology for measuring thrombus or sinus 
size. These results should therefore be considered as hypothesis‐generating. Volumetric 
studies done manually are naturally also prone to errors, but in this study the correlation 
between individual measurers using the same methodology was good, the highest 
reproducibility found in volume measurements. These volume measurements have more 
dimensions and attempt to measure the actual real‐life clot size compared to more rater‐
dependent and less objective area and length measurements. However, this study also 
has certain strengths. Firstly, it brings a novel approach in evaluating CVT patients. 
Secondly, all calculations were done on state‐of‐the‐art MR images.  
Larger studies investigating the sinus and thrombus volumes and the possible 
implementation to clinical practice are warranted to reveal significance of our method and 
findings.  Manual measurements used in this study are time‐consuming but also likely 
more reliable compared to automated calculations, especially when implementing a novel 
method. One possibility could be a user‐supervised reliable automated software 
developed for measuring the sinuses and the clots. 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